Skip to main content
Erschienen in: Internal and Emergency Medicine 1/2020

17.10.2019 | IM - REVIEW

Renal involvement in adrenal insufficiency (Addison disease): can we always recognize it?

verfasst von: Claudia Fofi, Barbara Maresca, Silvia Altieri, Paolo Menè, Francescaromana Festuccia

Erschienen in: Internal and Emergency Medicine | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Addison disease is due to the destruction or dysfunction of the entire adrenal cortex. Nowadays, the causes of adrenal insufficiency are autoimmune disease for 70–90% and tuberculosis for 7–20%. Many typical signs and symptoms, such as hyponatremia, hyperkalaemia, or renal insufficiency can represent the reasons for a nephrology consultation, especially in conditions of urgency, and they can easily be confused with other causes. Moreover, the fact that in a short time range we have diagnosed the three cases described as a guide in this review, has aroused our attention as nephrologists on a disease in which we have probably already encountered but without recognizing it. The blood tests showed in all three patients severe electrolyte disorders and acute renal failure which will be discussed in their physiopathogenetic mechanisms. In a peculiar way, these alterations were not controlled with repolarizing solutions, fluid replacement and increased volemia, but only after steroid administration. In conclusion, in this review all the known pathogenic mechanisms causing disorders of nephrological interest in adrenal insufficiency are discussed.
Literatur
1.
Zurück zum Zitat Addison T (1855) On the constitutional and local effects of disease of the suprarenal capsules. Highley, London Addison T (1855) On the constitutional and local effects of disease of the suprarenal capsules. Highley, London
2.
Zurück zum Zitat Irvine WJ, Barnes EW (1972) Adrenocortical insufficiency. Clin Endocrinol Metab 1:549 Irvine WJ, Barnes EW (1972) Adrenocortical insufficiency. Clin Endocrinol Metab 1:549
3.
Zurück zum Zitat Zelissen PM, Bast EJ, Croughs RJ (1995) Associated autoimmunity in Addison's disease. J Autoimmun 8:121–130PubMed Zelissen PM, Bast EJ, Croughs RJ (1995) Associated autoimmunity in Addison's disease. J Autoimmun 8:121–130PubMed
4.
Zurück zum Zitat Kasperlik-Zaluska AA, Migdalska B, Czarnocka B et al (1991) Association of Addison's disease with autoimmune disorders—a long-term observation of 180 patients. Postgrad Med J 67:984–987PubMedPubMedCentral Kasperlik-Zaluska AA, Migdalska B, Czarnocka B et al (1991) Association of Addison's disease with autoimmune disorders—a long-term observation of 180 patients. Postgrad Med J 67:984–987PubMedPubMedCentral
5.
Zurück zum Zitat Moreira AC, Martinez R, Castro M, Elias LL (1992) Adrenocortical dysfunction in paracoccidioidomycosis: comparison between plasma beta-lipotrophin/adrenocorticotrophin levels and adrenocortical tests. Clin Endocrinol 36:545–551 Moreira AC, Martinez R, Castro M, Elias LL (1992) Adrenocortical dysfunction in paracoccidioidomycosis: comparison between plasma beta-lipotrophin/adrenocorticotrophin levels and adrenocortical tests. Clin Endocrinol 36:545–551
6.
Zurück zum Zitat Nomura K, Demura H, Saruta T (1994) Addison's disease in Japan: characteristics and changes revealed in a nationwide survey. Intern Med 33:602–606PubMed Nomura K, Demura H, Saruta T (1994) Addison's disease in Japan: characteristics and changes revealed in a nationwide survey. Intern Med 33:602–606PubMed
7.
8.
Zurück zum Zitat Laureti S, Vecchi L, Santeusanio F, Falorni A (1999) Is the prevalence of Addison's disease underestimated? J Clin Endocrinol Metab 84:1762PubMed Laureti S, Vecchi L, Santeusanio F, Falorni A (1999) Is the prevalence of Addison's disease underestimated? J Clin Endocrinol Metab 84:1762PubMed
9.
Zurück zum Zitat Erichsen MM, Lovas K, Skinnisqrud B et al (2009) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 94:4882–4890PubMed Erichsen MM, Lovas K, Skinnisqrud B et al (2009) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 94:4882–4890PubMed
10.
Zurück zum Zitat Cutolo M (2014) Autoimmune polyendocrine syndrome Auitoimmun Rev 13:85–89 Cutolo M (2014) Autoimmune polyendocrine syndrome Auitoimmun Rev 13:85–89
11.
Zurück zum Zitat Brandao Neto RA, De Carvalho JF (2014) Diagnosis and classification of Addison’s disease (autoimmune adrenalitis). Autoimmun Rev 13:408–411PubMed Brandao Neto RA, De Carvalho JF (2014) Diagnosis and classification of Addison’s disease (autoimmune adrenalitis). Autoimmun Rev 13:408–411PubMed
12.
Zurück zum Zitat Olafsson AS, Sigurjonsdottir HA (2016) Increasing prevalence of Addoson disease: results from a nationwidw study. Endocr Pract 22:30–35PubMed Olafsson AS, Sigurjonsdottir HA (2016) Increasing prevalence of Addoson disease: results from a nationwidw study. Endocr Pract 22:30–35PubMed
13.
Zurück zum Zitat Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndrome: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327–364PubMed Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndrome: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327–364PubMed
14.
Zurück zum Zitat Lombardi M, Michelassi S, Betterle C (2013) Conoscerlo per riconoscerlo: morbo di Addison con sindrome poliendocrina autoimmune di tipo II. Giornale di Tecniche Nefrologiche e Dialitiche 25:37–42 Lombardi M, Michelassi S, Betterle C (2013) Conoscerlo per riconoscerlo: morbo di Addison con sindrome poliendocrina autoimmune di tipo II. Giornale di Tecniche Nefrologiche e Dialitiche 25:37–42
15.
Zurück zum Zitat Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G (2006) Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 91:4849–4853PubMed Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G (2006) Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 91:4849–4853PubMed
16.
Zurück zum Zitat Muls E, Bouillon R, Boelaert J et al (1982) Etiology of hypercalcemia in a patient with Addison’s desease. Calcif Tissue Int 34:523–526PubMed Muls E, Bouillon R, Boelaert J et al (1982) Etiology of hypercalcemia in a patient with Addison’s desease. Calcif Tissue Int 34:523–526PubMed
17.
Zurück zum Zitat Arlt W, Allolio B (2003) Adrenal insufficiency. Lancet 361:1881–1893PubMed Arlt W, Allolio B (2003) Adrenal insufficiency. Lancet 361:1881–1893PubMed
18.
Zurück zum Zitat Bornstein SR, Allolio B, Arlt W et al (2016) Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:364–389PubMed Bornstein SR, Allolio B, Arlt W et al (2016) Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:364–389PubMed
19.
Zurück zum Zitat Lau SY, Yong TY (2012) Rhabdomyolysis in acute primary adrenal insufficiency complicated by severe hyponatremia. Intern Med 51:2371–2374PubMed Lau SY, Yong TY (2012) Rhabdomyolysis in acute primary adrenal insufficiency complicated by severe hyponatremia. Intern Med 51:2371–2374PubMed
20.
Zurück zum Zitat Maguet H, Carreau A, Hautefeuille S et al (2017) An Addison disease revealed with a serious hyponatremia. Ann Biol Clin 75:87–91 Maguet H, Carreau A, Hautefeuille S et al (2017) An Addison disease revealed with a serious hyponatremia. Ann Biol Clin 75:87–91
21.
Zurück zum Zitat Oelkers W (1989) Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 321:492–496PubMed Oelkers W (1989) Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 321:492–496PubMed
22.
Zurück zum Zitat Ishikawa S, Schrier RW (1982) Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats. Kidney Int 22:587–593PubMed Ishikawa S, Schrier RW (1982) Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats. Kidney Int 22:587–593PubMed
23.
Zurück zum Zitat Kamoi K, Tamura T, Tanaka K et al (1993) Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency. J Clin Endocrinol Metab 77:1584–1588PubMed Kamoi K, Tamura T, Tanaka K et al (1993) Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency. J Clin Endocrinol Metab 77:1584–1588PubMed
25.
Zurück zum Zitat Correia F, Fernandes A, Mota TC et al (2015) Hyponatremia in a teenager: a rare diagnosis. Pediatr Emerg Care 31:860–863PubMed Correia F, Fernandes A, Mota TC et al (2015) Hyponatremia in a teenager: a rare diagnosis. Pediatr Emerg Care 31:860–863PubMed
26.
Zurück zum Zitat Waise A, Young RJ (1989) Pitfalls in the management of acute adrenocortical insufficiency: discussion paper. J R Soc Med 82:741–742PubMedPubMedCentral Waise A, Young RJ (1989) Pitfalls in the management of acute adrenocortical insufficiency: discussion paper. J R Soc Med 82:741–742PubMedPubMedCentral
27.
Zurück zum Zitat Connor A, Care S, Taylor J (2010) Addison’s disease presenting with acute kidney injury. Clin Med 10:15–16 Connor A, Care S, Taylor J (2010) Addison’s disease presenting with acute kidney injury. Clin Med 10:15–16
28.
Zurück zum Zitat Thompson MD, Kalmar E, Bowden SA (2015) Severe hyponatremia with absence of hyperkalaemia in rapidly progressive Addison’s disease. BMJ Case Rep. doi: https://mc.manuscriptcentral.com/bmjcasereports10.1136/bcr-2015–209903 Thompson MD, Kalmar E, Bowden SA (2015) Severe hyponatremia with absence of hyperkalaemia in rapidly progressive Addison’s disease. BMJ Case Rep. doi: https://​mc.​manuscriptcentra​l.​com/​bmjcasereports10​.​1136/​bcr-2015–209903
29.
Zurück zum Zitat Fraser R (1984) Disorders of the adrenal cortex: their effects on electrolyte metabolism. Clin Endocrinol Metab 13:413–430PubMed Fraser R (1984) Disorders of the adrenal cortex: their effects on electrolyte metabolism. Clin Endocrinol Metab 13:413–430PubMed
30.
Zurück zum Zitat Talbott JH, Pecora LJ, Melville RS, Consolazio WV (1942) Renal function in patients with Addison’s disease and in patients with adrenal insufficiency secondary to pituitary pan-hypofunction. J Clin Invest 21:107–119PubMedPubMedCentral Talbott JH, Pecora LJ, Melville RS, Consolazio WV (1942) Renal function in patients with Addison’s disease and in patients with adrenal insufficiency secondary to pituitary pan-hypofunction. J Clin Invest 21:107–119PubMedPubMedCentral
31.
Zurück zum Zitat Harvey TC (2007) Addison’s disease and the regulation of potassium: the role of insulin and aldosterone. Med Hypotheses 69:1120–1126PubMed Harvey TC (2007) Addison’s disease and the regulation of potassium: the role of insulin and aldosterone. Med Hypotheses 69:1120–1126PubMed
32.
Zurück zum Zitat Maki S, Kramarz C, Heister MP, Pasha K. (2016) First presentation of Addison’s disease as hyperkalemia in acute kidney injury. BMJ Case Rep. doi: https://mc.manuscriptcentral.com/bmjcasereports10.1136/bcr-2015-213375 Maki S, Kramarz C, Heister MP, Pasha K. (2016) First presentation of Addison’s disease as hyperkalemia in acute kidney injury. BMJ Case Rep. doi: https://​mc.​manuscriptcentra​l.​com/​bmjcasereports10​.​1136/​bcr-2015-213375
33.
Zurück zum Zitat Siengler DI (1970) Idiopatic Addison’s disease presenting with hypercalcemia. Br Med J 2:522 Siengler DI (1970) Idiopatic Addison’s disease presenting with hypercalcemia. Br Med J 2:522
34.
Zurück zum Zitat Diamond T, Thornley S (1994) Addisonian crisis and hypercalcemia. Aust N Z J med 24:316PubMed Diamond T, Thornley S (1994) Addisonian crisis and hypercalcemia. Aust N Z J med 24:316PubMed
35.
Zurück zum Zitat Montoli A, Colussi G, Minetti L (1992) Hypercalcemia in Addison’s disease: calciotropic hormone profile and bone hystology. J Intern Med 232:535–540PubMed Montoli A, Colussi G, Minetti L (1992) Hypercalcemia in Addison’s disease: calciotropic hormone profile and bone hystology. J Intern Med 232:535–540PubMed
36.
Zurück zum Zitat Miell J, Wassif W, McGregor A et al (1991) Life-threatening hypercalcaemia in association with Addisonian crisis. Postgrad Med J 67:770–772PubMedPubMedCentral Miell J, Wassif W, McGregor A et al (1991) Life-threatening hypercalcaemia in association with Addisonian crisis. Postgrad Med J 67:770–772PubMedPubMedCentral
37.
Zurück zum Zitat Yamamoto S, Okada Y, Arao T, Tanaka Y (2015) Secondary adrenocortical insufficiency complicated by marked hypercalcemia and eosinophilia: a case report. J UOEH 37:55–60PubMed Yamamoto S, Okada Y, Arao T, Tanaka Y (2015) Secondary adrenocortical insufficiency complicated by marked hypercalcemia and eosinophilia: a case report. J UOEH 37:55–60PubMed
38.
Zurück zum Zitat Walser M, Robinson BH, Duckett JW (1963) The hypercalcemia of adrenal insufficiency. J Clin Inv 42:456–465 Walser M, Robinson BH, Duckett JW (1963) The hypercalcemia of adrenal insufficiency. J Clin Inv 42:456–465
39.
Zurück zum Zitat Guleke P (1911) Experimentelle untersuchungen uber tetanic. Langenbecks Arch Klin Chir 94:496 Guleke P (1911) Experimentelle untersuchungen uber tetanic. Langenbecks Arch Klin Chir 94:496
40.
Zurück zum Zitat Loeb RF (1932) Chemical changes in the blood in Addison’s disease. Science 76:420PubMed Loeb RF (1932) Chemical changes in the blood in Addison’s disease. Science 76:420PubMed
41.
Zurück zum Zitat Downie WW, Gunn A, Paterson CR, Howie GF (1977) Hypercalcemic crisis as presentation of Addison’s disease. Br Med J 1:145–146PubMedPubMedCentral Downie WW, Gunn A, Paterson CR, Howie GF (1977) Hypercalcemic crisis as presentation of Addison’s disease. Br Med J 1:145–146PubMedPubMedCentral
42.
Zurück zum Zitat Quinkler M, Ekman B, Zhang P (2018) EU-AIR Investigators. Mortality data from the European Adrenal Insufficiency Registry – Patient characterization and associations. Clin Endocr 89:30–35PubMed Quinkler M, Ekman B, Zhang P (2018) EU-AIR Investigators. Mortality data from the European Adrenal Insufficiency Registry – Patient characterization and associations. Clin Endocr 89:30–35PubMed
44.
Zurück zum Zitat Anglin RE, Rosebush PI, Mazurek MF (2006) The neuropsychiatric profile of Addison’s disease: revisiting a forgotten phenomenon. J Neuropsychiatry Clin Neurosci 18:450–459PubMed Anglin RE, Rosebush PI, Mazurek MF (2006) The neuropsychiatric profile of Addison’s disease: revisiting a forgotten phenomenon. J Neuropsychiatry Clin Neurosci 18:450–459PubMed
Metadaten
Titel
Renal involvement in adrenal insufficiency (Addison disease): can we always recognize it?
verfasst von
Claudia Fofi
Barbara Maresca
Silvia Altieri
Paolo Menè
Francescaromana Festuccia
Publikationsdatum
17.10.2019
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 1/2020
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02209-x

Weitere Artikel der Ausgabe 1/2020

Internal and Emergency Medicine 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.